Exact Sciences is developing a blood-based screening method for colorectal cancer. Samples collected from the BLUE-C clinical trial will be used to establish the performance characteristics of this test. A blood test will be another addition to our portfolio of colorectal cancer screening options to reach the 44 million Americans who need to be screened for colorectal cancer.
